Neoadjuvant Therapy of Sintilimab Combined With Chemotherapy for Resectable Squamous Cell NSCLC（neoSCORE Ⅱ）
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
A Study of ARX788 Combined With Pyrotinib Maleate Versus TCBHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HER2-positive Breast Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study for the Adjuvant Treatment of Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE4
A Study for the Neoadjuvant Treatment of Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE4
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC
- Status
- SUSPENDED
- Phase
- PHASE1
Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Electrochemotherapy With Carboplatinum Plus Bleomycin Versus Bleomycin Alone in Vulvar Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Chemoradiation Plus Tislelizumab for Conversion Therapy of Locally Nonresectable ESCC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Trial of GFH018 and Toripalimab in Combination With Concurrent Chemoradiotherapy in Stage III NSCLC Chemoradiotherapy in Stage III NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of ASP3082 in Adults With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3